Literature DB >> 11309356

Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.

P A Hershberger1, W D Yu, R A Modzelewski, R M Rueger, C S Johnson, D L Trump.   

Abstract

We demonstrated that calcitriol has antiproliferative activity in squamous cell carcinoma and prostatic adenocarcinoma and enhances the antitumor activity of platinum-based agents. In this study, we examined whether calcitriol also increases paclitaxel cytotoxicity. The effect of treatment on growth of the murine squamous cell carcinoma (SCCVII/SF) and human prostatic adenocarcinoma (PC-3) was determined by clonogenic assay, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, and monitoring tumor growth. Treatment of SCC or PC-3 cells in vitro with calcitriol prior to paclitaxel significantly reduced clonogenic survival compared with either agent alone. Median-dose effect analysis revealed that calcitriol and paclitaxel interact synergistically. Treatment of SCC or PC-3 tumor-bearing mice with calcitriol prior to paclitaxel resulted in substantially greater growth inhibition than was achieved with either agent alone, supporting the combined use of calcitriol and paclitaxel in the treatment of solid tumors. To explore the molecular basis for the enhanced antitumor activity of this combination, the effect of treatment on p21(Waf-1) (p21), Bcl-2, and poly(ADP-ribose) polymerase expression was evaluated in PC-3. A 72-h pretreatment with calcitriol reduced p21 expression and increased paclitaxel cytotoxicity (measured after 24 h) without evidence of apoptosis [poly(ADP-ribose) polymerase cleavage]. After 48 h, paclitaxel induced apoptosis, the extent of which was increased similarly by pretreatment or concurrent treatment with calcitriol. We therefore propose a model for calcitriol enhancement of paclitaxel cytotoxicity in which the "early" (24 h) effects are schedule dependent and not attributed to enhancement of paclitaxel-induced apoptosis. In contrast, the "delayed" (48-h) enhancement of paclitaxel activity by calcitriol is schedule independent and associated with acceleration of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309356

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  54 in total

1.  Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D 3.

Authors:  Molly L Bristol; Xu Di; Matthew J Beckman; Eden N Wilson; Scott C Henderson; Aparna Maiti; Zhen Fan; David A Gewirtz
Journal:  Autophagy       Date:  2012-04-13       Impact factor: 16.016

2.  Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer.

Authors:  Victoria J Findlay; R Eric Moretz; Cindy Wang; Silvia G Vaena; Savannah G Bandurraga; Michael Ashenafi; David T Marshall; Dennis K Watson; E Ramsay Camp
Journal:  Mol Carcinog       Date:  2013-08-31       Impact factor: 4.784

3.  Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D.

Authors:  Youngtae Jeong; Srilatha Swami; Aruna V Krishnan; Jasmaine D Williams; Shanique Martin; Ronald L Horst; Megan A Albertelli; Brian J Feldman; David Feldman; Maximilian Diehn
Journal:  Mol Cancer Ther       Date:  2015-05-01       Impact factor: 6.261

4.  A switch between cytoprotective and cytotoxic autophagy in the radiosensitization of breast tumor cells by chloroquine and vitamin D.

Authors:  Eden N Wilson; Molly L Bristol; Xu Di; William A Maltese; Kristen Koterba; Matthew J Beckman; David A Gewirtz
Journal:  Horm Cancer       Date:  2011-10       Impact factor: 3.869

5.  Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracil.

Authors:  Agnieszka Kotlarz; Małgorzata Przybyszewska; Paweł Swoboda; Joanna Miłoszewska; Monika Anna Grygorowicz; Andrzej Kutner; Sergiusz Markowicz
Journal:  Tumour Biol       Date:  2015-10-28

6.  CYP24A1 inhibition enhances the antitumor activity of calcitriol.

Authors:  Josephia R Muindi; Wei-Dong Yu; Yingyu Ma; Kristie L Engler; Rui-Xian Kong; Donald L Trump; Candace S Johnson
Journal:  Endocrinology       Date:  2010-06-30       Impact factor: 4.736

Review 7.  The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.

Authors:  Meis Moukayed; William B Grant
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

8.  Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system.

Authors:  Yingyu Ma; Wei-Dong Yu; Alejandro A Hidalgo; Wei Luo; Remi Delansorne; Candace S Johnson; Donald L Trump
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

9.  The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis.

Authors:  Henrik C Horváth; Péter Lakatos; János P Kósa; Krisztián Bácsi; Katalin Borka; Giovanna Bises; Thomas Nittke; Pamela A Hershberger; Gábor Speer; Enikö Kállay
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

10.  Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy.

Authors:  Aruna V Krishnan; Srilatha Swami; Lihong Peng; Jining Wang; Jacqueline Moreno; David Feldman
Journal:  Endocrinology       Date:  2009-11-11       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.